Persongen Biotherapeutics (suzhou) Co., Ltd.
Clinical trials sponsored by Persongen Biotherapeutics (suzhou) Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New CAR-T therapy takes on tough blood cancers Results expected Sep 2026 (estimated)
- Experimental CAR-T therapy targets tough T-Cell cancers in new trial Results expected Oct 2026 (estimated)
- New shot aims to control Hard-to-Treat blood cancers Results expected Dec 2026 (estimated)